MarketPulse

EPS guidance

7 articles
BenzingaBenzinga··Vandana Singh

Becton Dickinson Beats Estimates, Boosts Guidance Amid Strong Medical Device Demand

Becton Dickinson surges 5.9% after beating Q2 estimates with $4.71B revenue and raising full-year profit guidance to $12.52-$12.72 EPS.
BDXearningsrevenue growth
The Motley FoolThe Motley Fool··Lee Samaha

GE Healthcare Tumbles 11.3% as $250M Cost Surge Crushes Q1 Earnings

GE Healthcare stock fell 11.3% after $250M cost surge cut Q1 EPS by $0.43, with full-year guidance reduced by $0.15 per share.
GEHCearningsinflation
BenzingaBenzinga··Lekha Gupta

Southern Company Powers Ahead With Beat Quarter, Raises Long-Term Outlook

Southern Company delivered Q1 FY2026 EPS beat of $1.32 vs. $1.21 consensus, with revenue of $8.4B. Stock rallied 2.44% as utility demand surges.
SOSOJCSOJDSOJESOJF+1earnings beatkilowatt-hour sales
BenzingaBenzinga··Vandana Singh

Ligand Pharmaceuticals Acquires XOMA for $739M to Expand Royalty Portfolio

Ligand Pharmaceuticals acquires XOMA Royalty for $739M, immediately accretive to EPS with 2026 guidance raised to $8.50–$9.50 per share.
LGNDXOMAXOMAOXOMAPacquisitionM&A
BenzingaBenzinga··Na

Ligand to Acquire XOMA Royalty for $739M, Bolstering Biopharma Portfolio to 200+ Assets

Ligand Pharmaceuticals to acquire XOMA Royalty for $39/share in $739M cash deal, expanding portfolio and raising 2026 EPS guidance.
LGNDXOMAXOMAOXOMAPacquisitionbiopharmaceutical
BenzingaBenzinga··Lekha Gupta

AT&T Reaffirms 2026 Outlook, Accelerates Fiber Expansion With Lumen Acquisition

AT&T reaffirms 2026 guidance, completes Lumen fiber acquisition adding 1M+ subscribers and 4M fiber locations, plans $45B shareholder returns.
TTBBTpATpCLUMN+1shareholder returnscapital investment
BenzingaBenzinga··Lekha Gupta

Global Payments Raises 2026 Guidance, Authorizes $2.5B Buyback Program

Global Payments beat earnings expectations and raised 2026 guidance. Company authorized $2.5B buyback program, boosting stock 12.94%.
GPNearningsdividend